News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Investing.com97d agoneutral
Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?Investopedia97d agobullish
Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZenecaBarrons.com97d agobearish
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZenecaThe Wall Street Journal97d agobearish
U.S. Stock Futures Rise, Oil Falls as U.S. Shifts Toward Diplomacy with IranThe Wall Street Journal97d agobearish
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger TalksPA Media: Money97d agoneutral
AstraZeneca in talks over £300bn mega-merger with US rival - reportsInvesting.com98d agoneutral
AstraZeneca and Bristol-Myers Squibb in talks over potential merger - ReportMT Newswires100d agoneutral
AbbVie Trims Full-Year Profit Outlook Due to Apogee AcquisitionBioPharma Dive100d agoneutral
Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOsSimply Wall St.100d agobullish
Bristol Myers Squibb (BMY) Earnings Beat And Higher Outlook Put Valuation Back In FocusGuruFocus.com101d agobullish
Bristol-Myers Squibb Co (BMY) (Q2 2026) Earnings Call Highlights: Growth Portfolio Surges 14%, ...